C
CAPR
Capricor Therapeutics Inc
31.68
-0.43-1.34%After Hours: 31.68 0.00 0.00%18:06 04/06 EDT
OPEN/PREV CLOSE31.37/31.68
TODAY RANGE30.33-31.61
VOL453.66K
MARKET CAP1.81B
52 WEEK RANGE4.300-40.37
AVG VOL (3M)1.36M
% TURNOVER0.79%
TURNOVER--
P/E (TTM)-13.8954
% RANGE4.02%
EPS(TTM)-2.2601
P/E(FORWARD)-30.1971
P/B5.89
BVPS5.33
DIVIDEND--
P/S62.42
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.56B
SHARES OUTSTANDING57.51M
NEXT EARNINGS05/11-05/15
FREE FLOAT49.83M
LOT SIZE1
EX-DATE06/05/2019
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Capricor Therapeutics (CAPR) Valuation After New Deramiocel Data And Upcoming PDUFA Milestone
Simply Wall St·4d ago
Capricor Therapeutics (CAPR) Is Up 7.2% After HOPE-3 Data And PDUFA Update Has The Bull Case Changed?
TipRanks·03/20 12:45
Capricor Therapeutics price target raised to $43 from $41 at Roth Capital
TipRanks·03/20 11:16
Roth MKM Keeps Their Buy Rating on Capricor Therapeutics (CAPR)
Simply Wall St·03/19 21:06
Why Capricor Therapeutics (CAPR) Is Down 8.0% After FDA Resumes Deramiocel Review And Phase 3 Update
Simply Wall St·03/15 09:19
A Look At Capricor Therapeutics’ (CAPR) Valuation After FDA Resumes Deramiocel Review On New HOPE-3 Data
Simply Wall St·03/14 01:34
Capricor Therapeutics (CAPR) Posts US$50 Million H1 Loss Reinforcing Bearish Cash Burn Narrative
TipRanks·03/14 00:11
Capricor Therapeutics Nears Key Milestones After Earnings Call
Same Industry
Name/Symbol
Change%
Price